Maven Securities’s enVVeno Medical NVNO Stock Holding History

Maven Securities’s Portfolio NVNO Stock Details NVNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-2,511	Closed	-$295K	–	967
2024 Q3	$295K	Buy	+2,511	New	+$461K	0.01%	774

Other funds holding NVNO

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACM

Altium Capital Management New York $42M AUM

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

WIM

Westside Investment Management Santa Monica, California $653M AUM 28.36% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Maven Securities's NVNO Position: Q4 2024 in Review

Maven Securities sold out of enVVeno Medical (NVNO) in Q4 2024, closing a stake of 2,511 shares — an estimated $295K sold.

Maven Securities first reported a position in NVNO in Q3 2024 and held it in 1 quarter. The position peaked at $295K in Q3 2024. 34 funds tracked by Wall St. Rank hold NVNO as of Q4 2024.

Maven Securities reported no remaining enVVeno Medical position as of Q4 2024 after selling out during the quarter.
Maven Securities sold 2,511 enVVeno Medical shares in Q4 2024, an estimated $295K.
Maven Securities first reported a position in enVVeno Medical in Q3 2024 and held it in 1 quarter.
Maven Securities's enVVeno Medical position peaked at $295K in Q3 2024.
34 funds tracked by Wall St. Rank held enVVeno Medical as of Q4 2024.

Based on Maven Securities's 13F filing for Q4 2024, filed 14 Feb 2025.